Company intelligence / Profile preview

FutuRx

Ownership: Private
Employees: ~15
Development stage: Preclinical

Overview

FutuRx is Israel’s leading biotechnology incubator focused on transforming cutting-edge science into new therapeutic breakthroughs. It provides hands-on support and infrastructure to early-stage biopharma startups through partnerships with major global pharma companies and investors. Its model bridges the gap between concept and proof-of-concept for novel drug development.

Therapeutic areas: OncologyMetabolic DisordersNeurology
Modalities: Small moleculeBiologicAntibodyGene therapy
Industry: Investors

Partnerships

Johnson & Johnson Innovation – JJDCTakeda Ventures Inc.OrbiMed Israel PartnersLeaps by BayerIsraeli Innovation Authority

Beyond the preview

Go deeper on FutuRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FutuRx.

Explore the full profile